The Wall Street Journal has asked for comments on whether readers support the IOM’s recommendation that women be provided the full range of FDA-approved contraception without cost sharing. Please voice your support! Yes, the question is a bit biased – there’s no evidence that premiums will increase and the contraception will not be free since women will be paying for the insurance plan in part. But that’s even more reason to chime in and make your views known – we need to affirm how important this will be for women and their families. 

Take Action Donate
facebook twitter instagram search paper-plane